Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China
Jing Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongnan Mo(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Lan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuchen Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Beibei Yang(Fujian Medical University), Pei Wang(Icahn School of Medicine at Mount Sinai), Xuelian Chen(Chengdu Medical College), Xingyuan Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dawei Wu(Chinese PLA General Hospital), Dong Qu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Yang(Guangzhou University of Chinese Medicine), Weilong Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 66
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k